Rifampicin as Potent Inhibitor of COVID - 19 Main Protease: In-Silico Docking Approach
Authors:
- Himesh SoniHSHimesh Soni
- V.K. GautamVGV.K. Gautam
- Sarvesh SharmaSSSarvesh Sharma
- Jitender K MalikJMJitender K Malik
- 9 September 2020
- journal article
- Published by SASPR Edu International Pvt. Ltd in Saudi Journal of Medical and Pharmaceutical Sciences
- Vol. 6 (9) , 588-593